Stem Cells International最新文献

筛选
英文 中文
Therapeutic Targeting of Oxidative Stress in Hematopoietic Stem Cells: Current Strategies and Future Directions. 造血干细胞氧化应激的靶向治疗:当前策略和未来方向。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-11-10 eCollection Date: 2026-01-01 DOI: 10.1155/sci/9975574
Dharmaraj Senthilkumar, Sathish Kumar Venkatachalam, Nallusamy Duraisamy, Zaw Myo Hein, Vasudevan Ramachandran, Suresh Kumar, Muhammad Danial Che Ramli, Anastasiya Spaska
{"title":"Therapeutic Targeting of Oxidative Stress in Hematopoietic Stem Cells: Current Strategies and Future Directions.","authors":"Dharmaraj Senthilkumar, Sathish Kumar Venkatachalam, Nallusamy Duraisamy, Zaw Myo Hein, Vasudevan Ramachandran, Suresh Kumar, Muhammad Danial Che Ramli, Anastasiya Spaska","doi":"10.1155/sci/9975574","DOIUrl":"10.1155/sci/9975574","url":null,"abstract":"<p><p>The maintenance of blood homeostasis relies heavily on hematopoietic stem cells (HSC), whose function is highly sensitive to oxidative stress caused by disrupted equilibrium between reactive oxygen species (ROS) and antioxidant systems. This review provides a comprehensive examination of the current strategies aimed at therapeutically targeting oxidative stress in HSC, outlining both the challenges and the advancements in this domain. We discuss the intricate mechanisms by which oxidative stress disrupts HSC self-renewal, quiescence, and differentiation, as well as the implications for aging and hematological malignancies. The function of the hypoxic bone marrow microenvironment in reducing oxidative damage is highlighted alongside the metabolic adaptations that support HSC viability. Furthermore, we explore emerging therapeutic approaches, including antioxidants, gene editing technologies, and niche modulation, that aim to enhance HSC function and resilience in the face of oxidative stress. Drawing on recent preclinical and clinical findings, this review highlights the need for novel strategies that integrate a deeper understanding of redox biology with therapeutic interventions to enhance outcomes in HSC transplantation and regeneration. This integration of current findings and emerging strategies provides valuable insights for developing targeted therapies aimed at preserving HSC integrity in the treatment of hematologic diseases.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"9975574"},"PeriodicalIF":3.6,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149395281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cMet Inhibitor Promotes the Survival and Long-Term Efficacy of Transplanted Hepatic Stem/Progenitor Cells in Liver Cirrhosis. 一种cMet抑制剂促进肝硬化移植肝干/祖细胞的存活和长期疗效。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-30 eCollection Date: 2026-01-01 DOI: 10.1155/sci/7020341
Min Yan, Deyu Hu, Jiejuan Lai, Quanyu Chen, Jiayu Yu, Mei Ding, Lu Li, Hongbo Shi, Hongyu Zhang, Yu Chen, Lianhua Bai
{"title":"A cMet Inhibitor Promotes the Survival and Long-Term Efficacy of Transplanted Hepatic Stem/Progenitor Cells in Liver Cirrhosis.","authors":"Min Yan, Deyu Hu, Jiejuan Lai, Quanyu Chen, Jiayu Yu, Mei Ding, Lu Li, Hongbo Shi, Hongyu Zhang, Yu Chen, Lianhua Bai","doi":"10.1155/sci/7020341","DOIUrl":"https://doi.org/10.1155/sci/7020341","url":null,"abstract":"<p><strong>Background: </strong>Poor retention of transplanted stem cells in the liver cirrhosis milieu (LCM) which critically blunts long-term efficacy, remains unexplained. This study investigated the effects of a small peptide chemical compound (icMet) delivered intravenously for cMet receptor inhibition at the diethylnitrosamine (DEN)-induced middle-to-late cirrhotic liver stage (CLS<sub>8/9</sub>), focusing on apoptosis prevention, endogenous hepatic regeneration and the long-term efficacy of transplanted hepatic stem/progenitor cells (MLpvNG2 cells).</p><p><strong>Methods: </strong>C57BL/6 mice with CLS<sub>8/9</sub> liver injury were used as recipients. icMet was used before or during MLpvNG2 cell therapy. Tissues from CLS<sub>8/9</sub> livers were also used to generate conditioned medium (CM, CLS<sub>8/9</sub>CM) to observe MLpvNG2 cell activity in response to the injured liver-related cues. Results: Compared with CLS<sub>8/9</sub> mice without icMet, mice subjected to icMet administration showed increased survival rates of transplanted MLpvNG2 cells in the CLS<sub>8/9</sub> livers, as well as enhanced downstream hepatic repair and long-term healing. In CLS<sub>8/9</sub>CM cultures, the survival of MLpvNG2 cells within icMet was similar to that observed in CLS<sub>8/9</sub> livers. In terms of the underlying mechanisms, it is possible that icMet pretreatment promotes proliferation and prevents apoptosis of grafted MLpvNG2 cells, activating host hepatic functional differentiation, particularly sinusoidal reconstruction, which can initiate hepatocyte regeneration. In addition, the relieved fibrotic load could also favor repopulation by donor cells, leading to long-term treatment efficacy.</p><p><strong>Conclusions: </strong>A strategy involving a pre- or during cell treatment that blocks the cMet receptor achieves apoptosis resistance of transplanted MLpvNG2 cells in the LCM and promotes endogenous hepatic regeneration, leading to long-term treatment efficacy.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"7020341"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13720526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bone Marrow Mesenchymal Stem Cell-Derived Exosomal miR-451a Inhibits Macrophage M1 Polarization Through the TLR4/PI3K/AKT Signaling Pathway to Alleviate Acute Lung Injury. 骨髓间充质干细胞来源的外泌体miR-451a通过TLR4/PI3K/AKT信号通路抑制巨噬细胞M1极化,减轻急性肺损伤
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-26 eCollection Date: 2026-01-01 DOI: 10.1155/sci/5080421
Jiawu Yang, Yongze Liu, Qinglang Dai, Yuan Liao, Liang Zhao, Zhu Tian, Feng Li
{"title":"Bone Marrow Mesenchymal Stem Cell-Derived Exosomal miR-451a Inhibits Macrophage M1 Polarization Through the TLR4/PI3K/AKT Signaling Pathway to Alleviate Acute Lung Injury.","authors":"Jiawu Yang, Yongze Liu, Qinglang Dai, Yuan Liao, Liang Zhao, Zhu Tian, Feng Li","doi":"10.1155/sci/5080421","DOIUrl":"https://doi.org/10.1155/sci/5080421","url":null,"abstract":"<p><strong>Background: </strong>Abnormal polarization of macrophages toward the M1 phenotype is a key pathogenic mechanism in acute lung injury (ALI). Bone marrow mesenchymal stem cell (MSC)-derived exosomes (BMSC-Exos) represent a promising therapeutic approach to inhibit macrophage M1 polarization and alleviate ALI, but the molecular mediators involved are incompletely defined. This study aimed to identify the responsible exosomal mediator and to define its downstream signaling.</p><p><strong>Methods: </strong>An ALI mouse model was established via intratracheal LPS instillation, and a cell injury model was constructed using LPS-stimulated RAW264.7 cells. Exos were isolated from human BMSCs. Lung injury was assessed through HE staining, lung wet/dry weight ratio, bronchoalveolar lavage fluid (BALF) protein concentration, and total BALF cell count. The expression levels of related genes and proteins were assessed using RT-qPCR, western blotting, ELISA, and immunofluorescence.</p><p><strong>Results: </strong>Treatment with BMSC-Exos significantly ameliorated lung damage in ALI mice and reduced the lung wet/dry weight ratio, BALF protein concentration, and total inflammatory cell count. Additionally, BMSC-Exos reduced the expression of M1 macrophage markers (iNOS, CD80, and CD86) and proinflammatory cytokines (IL-1β, IL-6, and TNF-α), thereby inhibiting macrophage M1 polarization. Mechanistically, BMSC-Exos suppressed the LPS-induced activation of the PI3K/AKT signaling pathway, whereas the PI3K/AKT activator 740 Y-P weakened the inhibitory effect of BMSC-Exos on M1 polarization. The expression of miR-451a was significantly downregulated in ALI and enriched in BMSC-Exos. miR-451a inhibits the PI3K/AKT signaling pathway by targeting and suppressing TLR4 expression. miR-451a knockdown or TLR4 overexpression attenuated the therapeutic effects of BMSC-Exos on ALI.</p><p><strong>Conclusion: </strong>BMSC-Exos-derived miR-451a inhibited the PI3K/AKT signaling pathway by downregulating TLR4 expression, thereby suppressing macrophage M1 polarization and alleviating ALI.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"5080421"},"PeriodicalIF":3.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13710806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149288666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanisms of Neural Stem Cell Mediated Neurogenesis and Therapeutic Prospects Following Ischemic Stroke: A Review. 缺血性脑卒中后神经干细胞介导的神经发生机制及治疗前景综述。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-26 eCollection Date: 2026-01-01 DOI: 10.1155/sci/6934557
Shuhong Wang, Ji Zhang, Peng Wang, Peng Ye, Jin Wu, Lili Shi, Xuheng Jiang, Yuanlan Lu, Hongfei Ge, Anyong Yu
{"title":"Mechanisms of Neural Stem Cell Mediated Neurogenesis and Therapeutic Prospects Following Ischemic Stroke: A Review.","authors":"Shuhong Wang, Ji Zhang, Peng Wang, Peng Ye, Jin Wu, Lili Shi, Xuheng Jiang, Yuanlan Lu, Hongfei Ge, Anyong Yu","doi":"10.1155/sci/6934557","DOIUrl":"10.1155/sci/6934557","url":null,"abstract":"<p><p>Ischemic stroke is a refractory cerebrovascular disorder characterized by high incidence, disability, and mortality rates. Its core pathological features include extensive neuronal death within the ischemic zone and irreversible damage to neural circuits. Given the limited regenerative capacity of the central nervous system, regulating endogenous neurogenesis and reconstructing functional circuits are important strategies for treating neurological deficits. This narrative review summarizes the dynamic processes of activation, proliferation, migration, and differentiation of endogenous neural stem cells (NSCs) following ischemic stroke, and explores the therapeutic potential of exogenous NSC transplantation and its current applications. Distinct from existing reviews, this work systematically integrates neuroimmune crosstalk, metabolic reprogramming, and meningeal‑choroid‑plexus‑mediated niche regulation, further proposing a staged multimodal precision intervention framework. We also highlight critical confounding factors, including aging‑driven regenerative decline, and explicitly separate preclinical animal findings from limited human clinical evidence. Meanwhile, this review elucidates the core mechanisms through which neurogenesis mediates tissue repair and functional recovery in ischemic brain tissue. Furthermore, this review refines future research directions, such as spatiotemporally specific precision interventions and multimodal combination therapies, providing a systematic theoretical basis and research framework for developing novel NSC-based therapeutic strategies for ischemic stroke.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"6934557"},"PeriodicalIF":3.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13697000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149273280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Astaxanthin Inhibits ox-LDL-Induced Early Endothelial Progenitor Cells Oxidative Stress and Apoptosis Through Nrf2 Activation. 虾青素通过激活Nrf2抑制ox- ldl诱导的早期内皮祖细胞氧化应激和凋亡。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-26 eCollection Date: 2026-01-01 DOI: 10.1155/sci/1729848
Keqing Pan, Xiao Xu, Qijun Jiang, Zhigang Gong, Zhigang Li, Shifang Ding, Meichun Zhang
{"title":"Astaxanthin Inhibits ox-LDL-Induced Early Endothelial Progenitor Cells Oxidative Stress and Apoptosis Through Nrf2 Activation.","authors":"Keqing Pan, Xiao Xu, Qijun Jiang, Zhigang Gong, Zhigang Li, Shifang Ding, Meichun Zhang","doi":"10.1155/sci/1729848","DOIUrl":"https://doi.org/10.1155/sci/1729848","url":null,"abstract":"<p><p>Astaxanthin exerts potent protective effects against stem cell apoptosis. This study investigated the protective efficacy of astaxanthin against oxidized low-density lipoprotein (ox-LDL)-induced oxidative stress and apoptosis in endothelial progenitor cells (EPCs). Human early EPCs cultured in vitro were challenged with ox-LDL in the presence or absence of astaxanthin. Results showed that ox-LDL exposure significantly reduced nuclear factor-E2-related factor 2 (Nrf2) nuclear translocation in EPCs, while increasing oxidative stress and apoptosis rates. Astaxanthin pretreatment attenuated ox-LDL-induced reactive oxygen species (ROS) generation and EPC apoptosis, preserved mitochondrial membrane potential (MMP), and concomitantly enhanced nuclear Nrf2 accumulation while upregulating NQO1, HO-1, and glutathione (GSH) levels. Nrf2 small interfering RNA (siRNA)-mediated knockdown completely abolished astaxanthin-induced NQO1 and HO-1 upregulation. Mechanistically, astaxanthin promoted Akt phosphorylation (activation) and inhibited glycogen synthase kinase 3β (GSK-3β) phosphorylation. Pretreatment with LY294002 (a phosphoinositide 3-kinase/PI3K inhibitor) suppressed astaxanthin-induced Nrf2 nuclear translocation, exacerbated ROS production, and reduced NQO1 and GSH levels. Additionally, astaxanthin blocked ox-LDL-induced caspase-3 upregulation and preserved EPC migration and tube formation. Nrf2 siRNA eliminated the protective effects of astaxanthin on EPC ROS production, MMP preservation, apoptosis, and migration; tube formation was not assessed. Overall, these in vitro findings using cells from healthy donors provide mechanistic support for the potential role of astaxanthin in the PI3K/Akt/GSK-3/Nrf2 pathway. However, the application of astaxanthin in the prevention and treatment of atherosclerotic disease requires further validation in disease-relevant models and clinical studies, as the present study was limited to in vitro results.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"1729848"},"PeriodicalIF":3.6,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13711028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149288643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis of Preclinical Studies. 干细胞治疗间质性膀胱炎/膀胱疼痛综合征的疗效:临床前研究的系统回顾和荟萃分析
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-25 eCollection Date: 2026-01-01 DOI: 10.1155/sci/4556842
Tao Yang, Wu Tang, Yuanzhi Li, Junchao Wu, Huitao Wang, Xiang Zhao, Kewei Fang
{"title":"Efficacy of Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis of Preclinical Studies.","authors":"Tao Yang, Wu Tang, Yuanzhi Li, Junchao Wu, Huitao Wang, Xiang Zhao, Kewei Fang","doi":"10.1155/sci/4556842","DOIUrl":"https://doi.org/10.1155/sci/4556842","url":null,"abstract":"<p><strong>Background: </strong>Interstitial cystitis/bladder pain syndrome (IC/BPS) is a refractory urological disorder for which effective disease-modifying treatments remain limited. This meta-analysis evaluates the preclinical efficacy of stem cell interventions for IC/BPS and establishes an evidence-based roadmap for clinical translation.</p><p><strong>Methods: </strong>A systematic search of PubMed, Embase, Web of Science, and Cochrane Library was performed (up to July 8, 2025). Risk of bias was appraised using the SYRCLE framework. Our outcomes focused on bladder histopathology, local inflammatory markers, urodynamic profiles, voiding patterns, and nociceptive behaviors.</p><p><strong>Results: </strong>Eighteen studies (27 comparisons) evaluating interventions based on mesenchymal stem/stromal cells (MSCs) in rat models were included. Stem cell therapy significantly alleviated histopathological damage by reducing mast cell infiltration (SMD = -2.42), collagen deposition (SMD = -2.13), and apoptosis (SMD = -3.09), while suppressing proinflammatory cytokines (TNF-α, IL-6, IL-1β). Functionally, interventions increased bladder capacity (SMD = 2.69), prolonged intercontraction intervals (SMD = 2.39), and markedly alleviated visceral pain (SMD = -3.19). Subgroup analyses identified human embryonic stem cell (hESC)-derived multipotent mesenchymal stem cells (M-MSCs) as the most extensively validated reference type, though other cell types exhibited phenotype-specific potential. Furthermore, a dose of 1 × 10<sup>6</sup> cells/rat, localized bladder wall injection (BWI), and allogeneic sources were identified as the most favorable preclinical parameters among the evaluated studies.</p><p><strong>Conclusions: </strong>Stem cell therapy-predominantly represented by MSCs-represents a promising candidate intervention with potential disease-modifying properties for IC/BPS in preclinical models. To inform future trial designs, we suggest a preliminary, theoretically scaled human equivalent dose window of 2.0 × 10<sup>7</sup> to 5.0 × 10<sup>7</sup> cells, preferentially administered via localized BWI. By exploring optimal cellular parameters and translational barriers, this study provides an evidence-based reference framework to guide the transition of stem cell therapy from bench to bedside.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"4556842"},"PeriodicalIF":3.6,"publicationDate":"2026-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13695852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149273299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: "Effects of Transplanted Heparin-Poloxamer Hydrogel Combining Dental Pulp Stem Cells and bFGF on Spinal Cord Injury Repair". 更正:“移植肝素-波洛沙姆水凝胶联合牙髓干细胞和bFGF对脊髓损伤修复的影响”。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-23 eCollection Date: 2026-01-01 DOI: 10.1155/sci/9817341
{"title":"Correction to: \"Effects of Transplanted Heparin-Poloxamer Hydrogel Combining Dental Pulp Stem Cells and bFGF on Spinal Cord Injury Repair\".","authors":"","doi":"10.1155/sci/9817341","DOIUrl":"https://doi.org/10.1155/sci/9817341","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2018/2398521.].</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"9817341"},"PeriodicalIF":3.6,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13692835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149273274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human Induced Pluripotent Stem Cells in Rare Neurological Disorders: Opportunities and Challenges for Disease Modeling and Drug Discovery. 罕见神经系统疾病中的人类诱导多能干细胞:疾病建模和药物发现的机遇和挑战。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-21 eCollection Date: 2026-01-01 DOI: 10.1155/sci/1130043
Anja Harej Hrkać, Valentino Rački, Andrej Belančić, Jasna Kriz, Dinko Vitezić, Jasenka Mršić-Pelčić, Ganesh Acharya, Mukesh Varshney, Kristina Pilipović
{"title":"Human Induced Pluripotent Stem Cells in Rare Neurological Disorders: Opportunities and Challenges for Disease Modeling and Drug Discovery.","authors":"Anja Harej Hrkać, Valentino Rački, Andrej Belančić, Jasna Kriz, Dinko Vitezić, Jasenka Mršić-Pelčić, Ganesh Acharya, Mukesh Varshney, Kristina Pilipović","doi":"10.1155/sci/1130043","DOIUrl":"https://doi.org/10.1155/sci/1130043","url":null,"abstract":"<p><p>Rare disease is a condition that affects a small fraction of the population. In most cases, it has a known genetic cause but could also be associated with other contributing factors. As the affected individuals may exhibit diverse symptoms due to the genetic and phenotypic heterogeneity, non- or misdiagnosis of rare diseases is common. Their low incidence and prevalence present an obstacle to developing new therapies despite a major unmet need with only a few treatment options available. This is particularly relevant to rare neurological disorders as there are major difficulties in studying the mechanisms of initiation and progression of the central nervous system (CNS) disorders. Recent advances in biotechnology, specifically the use of human induced pluripotent stem cells (iPSCs) for modeling diseases, have been instrumental in providing a flexible platform that not only reflects the effects of genetic disturbances on the development of CNS disorders but also is capable of providing insights into complex multifactorial disorders. Whether the human iPSCs are harvested from the affected individuals or using the gene-editing tools on cells from healthy individuals, valuable models can now be made available for studying these orphan conditions. In this narrative review, we explore the benefits of using human iPSC models over the existing platforms of other primary cell lines and animal models for the disease modeling and drug discovery and discuss the limitations and future aspects of the iPSC use in the investigation of rare neurological disorders.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"1130043"},"PeriodicalIF":3.6,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13685662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fibrinogen Alpha Chain (FGA) Associates With Epithelial-Mesenchymal Transition, Stemness, and the USP-Catenin Complex in Colorectal Cancer. 结直肠癌中纤维蛋白原α链(FGA)与上皮-间质转化、干性和usp -连环蛋白复合物相关。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-19 eCollection Date: 2026-01-01 DOI: 10.1155/sci/9599574
Hao Lin, Weixu Chen, Qing Li
{"title":"Fibrinogen Alpha Chain (FGA) Associates With Epithelial-Mesenchymal Transition, Stemness, and the USP-Catenin Complex in Colorectal Cancer.","authors":"Hao Lin, Weixu Chen, Qing Li","doi":"10.1155/sci/9599574","DOIUrl":"10.1155/sci/9599574","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) progression is heavily driven by epithelial-mesenchymal transition (EMT) and the acquisition of cancer stem cell (CSC) properties. Elucidating the specific molecular drivers and dynamic indicators underlying these processes is crucial for advancing CRC management.</p><p><strong>Methods: </strong>The clinical significance and diagnostic value of fibrinogen alpha chain (FGA) were evaluated using TCGA data, immunohistochemistry (IHC), and paired pre- and postoperative serum samples. The biological functions of FGA were assessed in HCT116 cells through Transwell and 3D spheroid formation assays. Immunoprecipitation-mass spectrometry (IP-MS) and protein-protein interaction (PPI) network analyses were utilized to uncover the underlying molecular mechanisms.</p><p><strong>Results: </strong>FGA mRNA and protein are significantly upregulated in CRC tissues, and preliminary data indicate elevated serum FGA in CRC patients. Clinically, aberrant FGA expression correlates with tumor histological type, lymphatic invasion, and poor survival outcomes. In vitro, FGA overexpression is associated with the downregulation of E-cadherin, upregulation of mesenchymal markers (Vimentin, ZEB1, Snail), and increased cell migration and spheroid formation. Mechanistically, IP-MS identified a potential PPI network wherein FGA associates with ubiquitin-specific proteases (USP7, USP10) and the catenin complex (β-catenin, p120-catenin), suggesting a potential role in mediating pro-stemness signaling.</p><p><strong>Conclusion: </strong>These findings suggest that FGA may contribute to CRC plasticity by modulating EMT and stem-like properties in vitro. Furthermore, its dynamic postoperative reduction warrants further investigation to determine its utility for non-invasive tumor monitoring.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"9599574"},"PeriodicalIF":3.6,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13678855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149224601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FOXP1 Promotes Spermatogonial Stem Cell Proliferation by Transcriptionally Repressing GSK3B to Activate the Wnt/β-Catenin Signaling Pathway. FOXP1通过转录抑制GSK3B激活Wnt/β-Catenin信号通路促进精原干细胞增殖。
IF 3.6 3区 医学
Stem Cells International Pub Date : 2026-10-19 eCollection Date: 2026-01-01 DOI: 10.1155/sci/1109631
Jin-Hua Wu, Qing Feng, Feng Lin, Jiang-Ping Xie, Pei-Yan Liu, Yan-Hua Wang, Hui-Liang Zhou
{"title":"FOXP1 Promotes Spermatogonial Stem Cell Proliferation by Transcriptionally Repressing GSK3B to Activate the Wnt/β-Catenin Signaling Pathway.","authors":"Jin-Hua Wu, Qing Feng, Feng Lin, Jiang-Ping Xie, Pei-Yan Liu, Yan-Hua Wang, Hui-Liang Zhou","doi":"10.1155/sci/1109631","DOIUrl":"https://doi.org/10.1155/sci/1109631","url":null,"abstract":"<p><strong>Background: </strong>Nonobstructive azoospermia (NOA) is characterized by impaired spermatogenesis, yet the molecular mechanisms regulating spermatogonial stem cells (SSCs) in NOA remain unclear. Forkhead box protein P1 (FOXP1), a transcription factor implicated in cell proliferation and differentiation, may play a critical role in SSC function.</p><p><strong>Methods: </strong>Testicular tissues from OA and NOA patients were examined for FOXP1 expression using reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC). Cell viability, proliferation, and apoptosis were assessed by CCK-8, EdU, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays. The interaction between the FOXP1 and GSK3B promoter was analyzed via bioinformatics, chromatin immunoprecipitation, and luciferase reporter assays. Western blotting evaluated Wnt/β-catenin pathway activation. The role of this pathway was further confirmed by LiCl treatment in FOXP1-silenced SSCs.</p><p><strong>Results: </strong>FOXP1 was downregulated in NOA samples displaying defective spermatogenesis. FOXP1 knockdown inhibited SSC viability and proliferation while promoting apoptosis. Mechanistically, FOXP1 bound directly to the GSK3B promoter, repressing its transcription. Silencing FOXP1 increased GSK3B expression and suppressed Wnt/β-catenin signaling. Activation of Wnt/β-catenin by LiCl reversed the detrimental effects of FOXP1 knockdown on SSCs.</p><p><strong>Conclusion: </strong>FOXP1 positively regulates SSC proliferation and survival by transcriptionally repressing GSK3B and maintaining Wnt/β-catenin signaling. These findings highlight that the FOXP1-GSK3B-Wnt/β-catenin signaling axis plays an essential role in maintaining SSC homeostasis and spermatogenic function and provides novel mechanistic insights into the molecular pathogenesis of NOA.</p>","PeriodicalId":21962,"journal":{"name":"Stem Cells International","volume":"2026 ","pages":"1109631"},"PeriodicalIF":3.6,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13681013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149239544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书